Journal
POSTGRADUATE MEDICINE
Volume 122, Issue 1, Pages 139-143Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3810/pgm.2010.01.2107
Keywords
rosacea; inflammatory disease; pharmacotherapy; dermatological conditions
Categories
Ask authors/readers for more resources
Rosacea is a common chronic inflammatory disease of the skin and is associated with a number of etiological causes and inciting factors. It is characterized by erythematous charges of the facial skin, and commonly presents with papules, pustules, or telangiectasias The 4 subtypes of rosacea are categorized according to secondary symptoms, such as pain, erythema, dryness, and edema. A number of therapies are available to treat rosacea, some of which can be used in combination. The mainstays of therapy are topical metronidazole, topical azelaic acid, and oral tetracyclines. Other pharmacotherapeutic interventions have been shown to improve the signs and symptoms Of rosacea, although many of these have not yet received approval by the US Food and Drug Administration for this indication.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available